$Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response$

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haematologica (Roma) 2023-04, Vol.108 (4), p.1163-1167
Hauptverfasser:	Jallouk, Andrew P, Gouni, Sushanth, Westin, Jason, Feng, Lei, Mistry, Haleigh, Steiner, Raphael E, James, Jinsu, Noorani, Mansoor, Horowitz, Sandra, Puebla-Osorio, Nahum, Fayad, Luis E, Iyer, Swaminathan P, Hawkins, Misha, Flowers, Christopher R, Ahmed, Sairah, Nastoupil, Loretta J, Kebriaei, Partow, Shpall, Elizabeth J, Neelapu, Sattva S, Nieto, Yago, Strati, Paolo
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens, CD19 Biological Products - therapeutic use Humans Immunotherapy, Adoptive Letter to the Editor Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!